Replacement of Reduced Highly Unsaturated Fatty Acids (HUFA Deficiency) in Dilative Heart Failure: Dosage of EPA/DHA and Variability of Adverse Peroxides and Aldehydes in Dietary Supplement Fish Oils
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Objectives: To explore the rationale for ω-3 fatty acids in heart failure treatment, the dosage of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) for replacing low levels of highly unsaturated fatty acids (HUFA deficiency) was examined. To judge the usefulness of various EPA/DHA preparations, their content of peroxides and aldehydes was determined. Methods: In 298 patients with dilative heart failure, the serum HUFA level was assessed by gas chromatography. In ω-3-acid ethyl esters 90 (Omacor/Lovaza, approved by the Food and Drug Administration and the European Medicines Agency) and 63 dietary supplement fish oils, oxidation products were determined by photometry. Results: Increasing serum HUFA from the lower (4.3 ± 1.0%) to the upper (9.5 ± 1.5%) tertile would be associated with an increased left ventricular (LV) ejection fraction (34.1 ± 9.9 vs. 28.3 ± 9.5%, p < 0.01) and reduced LV enddiastolic diameter (63.5 ± 7.1 vs. 66.9 ± 7.4 mm) requiring at least 2 g EPA/DHA daily. In fish oils, the peroxide and alkenal level varied greatly, i.e. peroxide value ≤5 mEq/kg in only 7 and ≤10 mEq/kg in 38 fish oils. Compared with equivalent doses of ω-3-acid ethyl esters 90, the mean peroxide intake would be 8.6 ± 6.1 and the alkenal intake 10.9 ± 4.4 times higher in fish oils. Conclusions: Levels of adverse oxidation products should be considered when targeting HUFA deficiency or treating patients with myocardial infarction or high triglycerides.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some, 107 but not all, 108 supplements also contain unacceptable levels of oxidation products that have been shown to interfere with the beneficial effects of n-3 FAs in some, 109,110 but not all, 111 studies.”
From Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association (2019) · cites this paper as [109]
Citations
Cites
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
(1999) · PubMed · Cited by 2,062
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203859 · Cited by 929
Rauch, B., Schiele, R., Schneider, S., Diller, F., Victor, N., Gohlke, H., Gottwik, M., Steinbeck, G., Del Castillo, U., Sack, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.948562 · Cited by 607
GERSTER, H. (1998) · PubMed · Cited by 408
(n-3) Fatty Acids and Cardiovascular Health: Are Effects of EPA and DHA Shared or Complementary?
Mozaffarian, D., & Wu, J. H. Y. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.149633 · Cited by 368
Holubarsch, C. J. F., Rohrbach, M., Karrasch, M., Boehm, E., Polonski, L., Ponikowski, P., & Rhein, S. (2007) · Clinical Science · doi:10.1042/cs20060307 · Cited by 287
Cited by
Skulas-Ray, A. C., Wilson, P. W. F., Harris, W. S., Brinton, E. A., Kris-Etherton, P. M., Richter, C. K., Jacobson, T. A., Engler, M. B., Miller, M., Robinson, J. G., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000709 · Cited by 512
Bannenberg, G., Mallon, C., Edwards, H., Yeadon, D., Yan, K., Johnson, H., & Ismail, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-01470-4 · Cited by 87
Jairoun, A. A., Shahwan, M. J., & Zyoud, S. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244688 · Cited by 39
Bannenberg, G. L., Rice, H. B., Bernasconi, A. A., Ferrari, A., Mallon, C., Navarrete, L. F. M., Hughes, R., Igarashi, J., Persons, K., Latynski, L., et al. (2020) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2020.103435 · Cited by 37
Oxidation of fish oil supplements in Australia
Heller, M., Gemming, L., Tung, C., & Grant, R. (2019) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2018.1542666 · Cited by 37
“…exceeding at least one international limit for oxidation (Fantoni et al. 1996; Halvorsen and Blomhoff 2011; Opperman and Benade 2013; Ritter et al. 2013; Rupp et al. 2013; Albert et al. 2015; Jackowski et al. 2015; Bannenberg et al. 2017; Labdoor 2017; Mason and Sherratt 2017; De Boer et al. 2018).”
BackgroundGlück, T., & Alter, P. J. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.03.007 · Cited by 24
Self-citationFish Oil for Healthy Aging: Potential Application to Master Athletes
Murphy, C. H., & McGlory, C. (2021) · Sports Medicine · doi:10.1007/s40279-021-01509-7 · Cited by 11
Suzan, A. J., Garcia, P. H. D., Furlan, C. P. B., Barba, F. C. R., Franco, Y. E. M., Longato, G. B., Contesini, F. J., & Carvalho, P. D. O. (2022) · NFS Journal · doi:10.1016/j.nfs.2022.09.002 · Cited by 8
Mechanisms increasing n-3 highly unsaturated fatty acids in the heart
Glück, T., Rupp, H., & Alter, P. J. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0300 · Cited by 6
“2002a), the PPAR-alpha activator fenofibrate increased 20: 4n-6, while 20:5n-3 and 22:6n-3 were unaffected (Rupp et al. 2013).”
BackgroundSelf-citationReddy, K. J., & Chowdhury, S. (2016) · Future Cardiology · doi:10.2217/fca-2015-0009 · Cited by 5
Kovacic, P., & Somanathan, R. (2015) · Open Journal of Medicine
Kus-Yamashita, M. M. M. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2023.tde-15052023-105749
Metadata
- Authors
- Rupp, T. P., Rupp, K. G., Alter, P., & Rupp, H.
- Affiliations
- Philipps University of Marburg (DE)
- ORCID
- Alter, Peter
- Venue
- Cardiology
- Publisher
- S. Karger AG
- Published
- 2013
- Volume
- 125
- Issue
- 4
- Pages
- 223-231
- ISSN
- 0008-6312 (ISSN-L)
- 1421-9751
- OpenAlex
- W2012777696
- Cited by
- 12
- References
- 47
- Citations by year
- 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2017: 1 · 2016: 2 · 2015: 2
- FWCI
- 1.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Philipps-Universität Marburg
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Physical Sciences › Chemistry › Organic Chemistry › Edible Oils Quality and Analysis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- omega-3 fatty acids, EPA, docosahexaenoic acid, highly unsaturated fatty acids, fish oil supplements, omega-3 acid ethyl esters, lipid peroxidation, lipid hydroperoxides, lipid aldehydes, oxidative stability, dosage, left ventricular ejection fraction, left ventricular end-diastolic diameter
- MeSH terms
- Aldehydes, Cardiomyopathy, Dilated, Cardiotonic Agents, Docosahexaenoic Acids, Fatty Acids, Unsaturated, Fish Oils, Heart Failure, Humans, Myocardial Infarction, Peroxides, ROC Curve, Eicosapentaenoic Acid, Hypertriglyceridemia, Oxidants, Ventricular Dysfunction, Left, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.